STOCK TITAN

Planned Rule 144 sale of TSHA (TSHA) shares via Maxim Group

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A TSHA security holder filed a notice of proposed sale under Rule 144 to sell 46,064 shares of common stock through broker Maxim Group LLC on or about 01/23/2026 on the Nasdaq market, with an indicated aggregate market value of $234,465.76. The filing notes that there were 273,919,373 shares of this class outstanding at the time of the notice. The seller acquired these shares on 01/23/2026 via a vested RSU award from the issuer, with the consideration described as the reporting person’s continued service as an employee.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TSHA Form 144 filing disclose?

It discloses that a TSHA security holder plans to sell 46,064 shares of common stock under Rule 144 through Maxim Group LLC on or about 01/23/2026 on the Nasdaq market.

How many TSHA shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 46,064 shares of TSHA common stock, with an indicated aggregate market value of $234,465.76.

How were the TSHA shares in this Form 144 acquired?

The 46,064 TSHA common shares were acquired on 01/23/2026 via an RSU award from the issuer, described as a vested grant settled in stock in exchange for continued employment.

What is the number of TSHA shares outstanding referenced in the Form 144?

The Form 144 states that there were 273,919,373 shares of TSHA common stock outstanding at the time of the notice.

Which broker is handling the proposed TSHA Rule 144 sale?

The proposed sale of 46,064 TSHA common shares is listed as being handled by Maxim Group LLC, located at 300 Park Avenue, 16th Floor, New York, NY 10022.

What representation does the seller make in the TSHA Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about TSHA’s current or prospective operations that has not been publicly disclosed.
Taysha Gene Therapies, Inc.

NASDAQ:TSHA

TSHA Rankings

TSHA Latest News

TSHA Latest SEC Filings

TSHA Stock Data

1.39B
242.89M
11.15%
94.76%
14.95%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DALLAS